Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,114.2
-12.0 (-0.38%)

 

  • STI Straits Times Index
    3,114.2
    -12.0 (-0.38%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.2
    -3.4 (-0.21%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,719.6
    -128.9 (-0.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,938.1
    -39.2 (-1.32%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,492.7
    40.8 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,191.9
    10.9 (0.18%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,060.7
    -17.2 (-0.83%)
    Index delayed 20 minutes
  • XAO XAO
    6,758.4
    -33.1 (-0.49%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 937.3M
  • Value: 879.2M
  • Rise: 114
  • Fall: 160
  • Unch: 558

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MDR0.002-
Rex Intl0.093+0.005
ThaiBev0.900+0.025
Genting Sing0.915-0.010
Spackman0.016-
YZJ Shipbldg SGD0.940-0.010
Y Ventures0.112+0.001
AEM1.280+0.020
KLW0.003-
Singapore-eDev0.045-0.002

World Indices

World Indices
Name Last Change
Nasdaq 8,089.5 -67.3
HSI 26,719.6 -128.9
HSCEI 10,540.0 -48.1
Jakarta 6,191.9 +10.9
Nikkei 225 22,492.7 +40.8
SSE Comp 2,938.1 -39.2
Shanghai A 3,078.2 -41.1
Shanghai B 263.8 -3.3
PSE Comp 0.0
KOSPI 2,060.7 -17.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

KAZIA THERAPEUTICS LIMITED KAZIA THERAPEUTICS
Updated on 18 Oct 2019 (End of trading day)
Last (AUD): 0.480 Change: - High: 0.490 Remarks: -
Change (%): - Low: 0.470
Open 0.485 Yesterday's Close 0.48
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 26,406 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.16521 Trailing EPS (AUD) e -0.16521 NAV (AUD) b 0.2209
PE a - Trailing PE f - Price / NAV b 2.1729
Dividend (AUD) d - Cash In Hand (AUD) g 0.0874 Issued & Paid-up Shares c 62,166,700
Dividend Yield (%) d - Price / Cash In Hand g 5.492 Treasury Shares h -
Beta - 75 Daysi 0.225 R-Squared - 75 Days(%)i 0.21 Market Cap (M) 29.840
Beta - 500 Daysi 0.642 R-Squared - 500 Days (%)i 0.77 Enterprise Value (M) 24.870
Piotroski F Score 1 Exchange Code KZA Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 53.25 Free Float (%) 89.2
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 26 Nov 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Nov 2017.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference KAZIA THERAPEUTICS LIMITED ASX 29.840 - - 2.1729 -
Industry Biotechnology ASX 2,416.545 53.030 52.823 13.9589 0.997
Local Peer CSL ASX 113,904.993 42.456 42.456 15.2216 1.057
Local Peer POLYNOVO LIMITED ASX 1,586.611 - - 60.7595 -
Local Peer AVITA MEDICAL LTD ASX 1,217.372 - - 40.8805 -
Local Peer MESOBLAST LTD ASX 938.395 - - 1.3689 -
Local Peer NEXT SCIENCE LTD ASX 505.395 - - 14.5286 -
Local Peer STARPHARMA HOLDINGS LIMITED ASX 418.486 - - 9.8684 -
Local Peer TELIX PHARMACEUTIC ASX 401.449 - - 9.2907 -
Local Peer RESAPP HEALTH LIMITED ASX 264.577 - - 34.5455 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 261.020 84.928 - 15.5597 -
Local Peer PHYLOGICA LIMITED ASX 161.229 - - 25.3846 -
Local Peer CYNATA THERAPEUTICS LTD ASX 137.799 - - 12.5586 -
Local Peer IMMUTEP LTD ASX 108.559 - - -6.3636 -
Other Local Peers IMUGENE LIMITED (ASX), ORTHOCELL LIMITED (ASX), ONCOSIL MEDICAL LIMITED (ASX), BIONOMICS LTD (ASX), MEMPHASYS LTD (ASX), BIOTRON (ASX), RHINOMED LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), GENETIC TECHNOLOGIES (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), IMMURON LIMITED (ASX), REGENEUS LTD (ASX), ADALTA LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), CELLMID LIMITED (ASX), BIOXYNE LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), MEDIBIO LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CCP TECHNOLOGIES LTD (ASX), NOVITA HEALTHCARE LTD (ASX), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 121,571.387 14.483 15.277 11.2628 2.734
Global Peer GILEAD SCIENCES INC NASDAQ 82,205.269 15.070 13.804 3.6348 3.556
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CELGENE CORP NASDAQ 72,964.886 18.034 13.843 7.2595 -
Global Peer ILLUMINA INC NASDAQ 45,487.680 55.070 48.494 10.5004 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 45,297.278 21.607 20.450 8.9344 -
Global Peer BIOGEN INC NASDAQ 40,589.407 9.161 7.667 3.1336 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,989.185 13.496 15.943 3.3815 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,077.029 73.028 21.527 4.8614 0.821
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,066.179 284.356 16.546 2.1711 -
Other Global Peers SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), SEATTLE GENETICS INC (NASDAQ), WUXI BIO (HKEx), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), 3SBIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), GENSCRIPT BIO (HKEx), SPARK THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), NATERA INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), COHERUS BIOSCIENCES INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), VIVA BIOTECH (HKEx), FATE THERAPEUTICS (NASDAQ), ANAPTYSBIO INC (NASDAQ), ALECTOR INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), HAOHAI BIOTEC (HKEx), EPIZYME INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), INTREXON CORP (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), OMEROS CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), CHEMOCENTRYX INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ASCLETIS-B (HKEx), REPLIMUNE GROUP INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), CKLIFE SCIENCES (HKEx), ESSEX BIO-TECH (HKEx), SYNTHORX INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DERMIRA INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), XBIOTECH INC (NASDAQ), MERUS B V (NASDAQ), KADMON HLDGS INC (NYSE), PERSONALIS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), AGENUS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), LEE'S PHARM (HKEx), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ARDELYX INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), GERON CORP (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), PFENEX INC (NYSE American), SORRENTO THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), KAMADA (NASDAQ), ATHERSYS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), AFFIMED N V (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BBI LIFE SCI (HKEx), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), IMV INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), UNI-BIO GROUP (HKEx), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), AVEO PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NANOVIRICIDES INC (NYSE American), AVALON GLOBOCARE CORP (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SESEN BIO INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), NOVAVAX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), CHIMERIX INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TREVENA INC (NASDAQ), VERASTEM INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CEL-SCI CORP (NYSE American), ARAVIVE INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), CURIS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SELECTA BIOSCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), PORT (SET), ORGENESIS INC (NASDAQ), COHBAR INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), EQUILLIUM INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), NEWLINK GENETICS CORP (NASDAQ), VERMILLION INC (NASDAQ), CT ENTERPRISE (HKEx), CIDARA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), IBIO INC (NYSE American), VASCULAR BIOGENICS LTD (NASDAQ), INMUNE BIO INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), IVERIC BIO INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), SAVARA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), BIO-PATH HOLDINGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIOCARDIA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), BIOSINO BIO-TEC (HKEx), ALIMERA SCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), EXTRAWELL PHAR (HKEx), ORAGENICS INC (NYSE American), MICROBOT MEDICAL INC (NASDAQ), OCUGEN INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), BIOCEPT INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ISORAY INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), VAXART INC (NASDAQ), PRECIPIO INC (NASDAQ), TOCAGEN INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), Suntar Eco-City^ (SGX), DARE BIOSCIENCE INC (NASDAQ), ATYR PHARMA INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), ENDRA LIFE SCIENCES INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), HAO WEN HLDGS (HKEx), ADVAXIS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MGRC (Bursa), ONCONOVA THERAPEUTICS INC (NASDAQ), MEGASUN (Bursa), XENETIC BIOSCIENCES INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), TROVAGENE INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), QT Vascular (SGX), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SPHERIX INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), NEURALSTEM INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.020
-4.00 %
10 Days --0.020
-4.00 %
20 Days --0.025
-4.95 %
Medium Term Return 3 Months -+0.090
+23.08 %
6 Months ---
1 Year -+0.095
+24.68 %
Annualised Return Annualised --
+24.68 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.320 - 0.600 Change From 1 Year Low +0.160 % Change From 1 Year Low (%) +50.00
Change From 1 Year High -0.120 % Change From 1 Year High (%) -20.00
2 Years Range 0.320 - 0.800 Change From 2 Years Low +0.160 % Change From 2 Years Low (%) +50.00
Change From 2 Years High -0.320 % Change From 2 Years High (%) -40.00
5 Years Range 0.320 - 0.800 Change From 5 Years Low +0.160 % Change From 5 Years Low (%) +50.00
Change From 5 Years High -0.320 % Change From 5 Years High (%) -40.00
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Kazia Therapeutics Ltd. engages in the pharmaceutical drug development. It involves in preclinical research confirms efficacy of cantrixil which induces cell death in chemoresistant ovarian cancer stem cells. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
18 Oct 2019 0.485 0.490 0.470 0.480 26,406 -
17 Oct 2019 0.487 0.490 0.480 0.480 16,792 -
16 Oct 2019 0.500 0.500 0.490 0.490 42,337 -
15 Oct 2019 0.500 0.515 0.500 0.515 9,545 -
14 Oct 2019 0.500 0.500 0.500 0.500 - -
11 Oct 2019 0.530 0.530 0.500 0.500 74,880 -
10 Oct 2019 0.510 0.525 0.510 0.525 32,112 -
09 Oct 2019 0.530 0.530 0.510 0.510 11,930 -
08 Oct 2019 0.500 0.500 0.500 0.500 - -
07 Oct 2019 0.500 0.520 0.500 0.500 29,544 -
04 Oct 2019 0.530 0.530 0.500 0.500 10,666 -
03 Oct 2019 0.510 0.510 0.510 0.510 5,082 -
02 Oct 2019 0.540 0.540 0.510 0.510 44,468 -
01 Oct 2019 0.550 0.550 0.530 0.540 84,171 -
30 Sep 2019 0.540 0.590 0.540 0.570 117,939 -
27 Sep 2019 0.520 0.535 0.520 0.535 43,909 -
26 Sep 2019 0.530 0.530 0.510 0.525 25,349 -
25 Sep 2019 0.550 0.550 0.510 0.530 120,462 -
24 Sep 2019 0.550 0.550 0.540 0.550 15,862 -
23 Sep 2019 0.520 0.550 0.515 0.550 92,254 -
20 Sep 2019 0.525 0.550 0.505 0.505 112,706 -
19 Sep 2019 0.505 0.520 0.500 0.505 47,178 -
Summary
Current 2 Weeks
(07 Oct 2019 to 18 Oct 2019)
0.500 0.530 0.470 0.480 243,546 -
Previous 2 Weeks
(23 Sep 2019 to 04 Oct 2019)
0.520 0.550 0.470 0.500 560,162 -
4 Weeks from
(26 Aug 2019 to 20 Sep 2019)
0.370 0.530 0.360 0.505 705,510 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.